119 tracked 13F filers disclose a position in DCTH as of the latest SEC 13F filings, a combined $125.0M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | $16.6M | 1.8M | ▼−2.2% Reduced · −41K sh | Q1 2026 | |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $12.3M | 1.3M | →First observed position No prior filed position | Q1 2026 | |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | $9.2M | 733K | ▲+5.9% Added · +41K sh | Q2 2026 | |
| 4 | STATE STREET CORP | $8.6M | 679K | ▲+2.2% Added · +15K sh | Q2 2026 | |
| 5 | MILLENNIUM MANAGEMENT LLC | $5.5M | 588K | ▲+139% Added · +342K sh | Q1 2026 | |
| 6 | ALGERT GLOBAL LLC | $7.3M | 581K | ▲+298% Added · +435K sh | Q2 2026 | |
| 7 | Divisadero Street Capital Management, LP | $4.6M | 500K | —Held | Q1 2026 | |
| 8 | Ikarian Capital, LLC | $4.0M | 431K | —Held | Q1 2026 | |
| 9 | MORGAN STANLEY | $3.6M | 386K | ▲+25% Added · +77K sh | Q1 2026 | |
| 10 | ExodusPoint Capital Management, LP | $4.5M | 360K | ▲10× Added · +324K sh | Q2 2026 | |
| 11 | Private Wealth Advisors, LLC | $3.9M | 311K | ▼−47% Reduced · −281K sh | Q2 2026 | |
| 12 | GOLDMAN SACHS GROUP INC | $2.7M | 289K | ▼−51% Reduced · −299K sh | Q1 2026 | |
| 13 | Simplify Asset Management Inc. | $3.3M | 265K | ▲+1.4% Added · +4K sh | Q2 2026 | |
| 14 | NORTHERN TRUST CORP | $2.3M | 252K | ▲+4.7% Added · +11K sh | Q1 2026 | |
| 15 | ADAR1 Capital Management, LLC | $2.1M | 224K | —Held | Q1 2026 | |
| 16 | KENNEDY CAPITAL MANAGEMENT LLC | $1.9M | 208K | ▲+2.5% Added · +5K sh | Q1 2026 | |
| 17 | VANGUARD FIDUCIARY TRUST CO | $1.9M | 202K | →First observed position No prior filed position | Q1 2026 | |
| 18 | MARSHALL WACE, LLP | $1.8M | 192K | ▲+687% Added · +167K sh | Q1 2026 | |
| 19 | CIBC WORLD MARKET INC. | $1.8M | 190K | ▲+19% Added · +31K sh | Q1 2026 | |
| 20 | VANGUARD PORTFOLIO MANAGEMENT LLC | $1.7M | 178K | →First observed position No prior filed position | Q1 2026 | |
| 21 | RENAISSANCE TECHNOLOGIES LLC | $1.4M | 155K | ▼−57% Reduced · −206K sh | Q1 2026 | |
| 22 | Man Group plc | $1.6M | 128K | ▲+26% Added · +26K sh | Q2 2026 | |
| 23 | JANE STREET GROUP, LLC | $1.2M | 128K | ▼−40% Reduced · −84K sh | Q1 2026 | |
| 24 | Diametric Capital, LP | $1.5M | 123K | ▼−21% Reduced · −34K sh | Q2 2026 | |
| 25 | Trexquant Investment LP | $967K | 104K | ▼−12% Reduced · −14K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 11 funds opened a new position in DCTH and 19 added to an existing one, while 12 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 54 funds | $35.9B |
| NVIDIA CORPNVDA | 53 funds | $184.4B |
| GENERAL ELECTRICGE | 52 funds | $15.6B |
| UNITEDHEALTH GROUP INCUNH | 52 funds | $14.1B |
| INTUITIVE SURGICAL INCISRG | 52 funds | $13.9B |
| LAM RESEARCH CORPLRCX | 52 funds | $12.3B |
| CHEVRON CORPCVX | 52 funds | $12.0B |
| BOSTON SCIENTIFIC CORPBSX | 52 funds | $4.3B |
| MICROSOFT CORPMSFT | 51 funds | $122.9B |
| MICRON TECHNOLOGY INCMU | 51 funds | $15.1B |
| HOWMET AEROSPACE INCHWM | 51 funds | $8.0B |
| DANAHER CORPDHR | 51 funds | $7.0B |
Ranked by how many of DCTH's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Mar 6, 2026 | Pennell Sandra | Chief Financial Officer | Buy (P) | 6K | $50K |
| Mar 2, 2026 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER, Director | Buy (P) | 11K | $100K |
| Nov 21, 2025 | Sylvester John Richard | Director | Buy (P) | 4K | $39K |
| Nov 11, 2025 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER, Director | Buy (P) | 12K | $98K |
| Mar 19, 2024 | SALAMON STEVEN A J | Director | Buy (P) | 27K | $100K |
| Mar 19, 2024 | Aharon Gil | Director | Buy (P) | 27K | $100K |
| Dec 12, 2023 | Vukovic Vojo | Chief Medical Officer | Buy (P) | 40K | $120K |
| Dec 8, 2023 | MICHEL GERARD J | Chief Executive Officer, Director | Buy (P) | 34K | $100K |
| Nov 17, 2023 | Pennell Sandra | SVP of Finance, PFO and PAO | Buy (P) | 30K | $73K |
| Nov 17, 2023 | Rosalind Advisors, Inc. | Director | Buy (P) | 100K | $240K |
| Nov 16, 2023 | Hoffman David L. | See Remarks | Buy (P) | 40K | $99K |
| Nov 16, 2023 | Vukovic Vojo | Chief Medical Officer | Buy (P) | 60K | $149K |
Connected entities for DCTH
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/DCTH/capital-change-brief"
Use Arkolith's capital_change_brief for DCTH. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for DCTH. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.